Compared with other groups, the CP+-CpG NPs group resulted in a significant increase in the proportion of CD4+ T cells and CD8+ T cells, which indicated successful activation of the immune effects and inhibition of primary and metastatic tumors. This evidence concerns the gene CD8A and metastatic neoplasm.